{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:09:38Z","timestamp":1790388578779,"version":"4.1.0"},"reference-count":52,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2016,3,16]]},"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single-dose and multiple-dose administration of AMG 557, a human anti-inducible T cell co-stimulator ligand (ICOSL) monoclonal antibody, in subjects with systemic lupus erythematosus (SLE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with mild, stable SLE (n=112) were enrolled in two clinical trials to evaluate the effects of single (1.8\u2013210\u2005mg subcutaneous or 18\u2005mg intravenous) and multiple (6\u2005\u2013210\u2005mg subcutaneous every other week (Q2W)\u00d77) doses of AMG 557. Subjects received two 1 mg intradermal injections 28\u2005days apart of keyhole limpet haemocyanin (KLH), a neoantigen, to assess PD effects of AMG 557. Safety, PK, target occupancy, anti-KLH antibody responses, lymphocyte subset analyses and SLE-associated biomarkers and clinical outcomes were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>AMG 557 demonstrated an acceptable safety profile. The PK properties were consistent with an antibody directed against a cell surface target, with non-linear PK observed at lower concentrations and linear PK at higher concentrations. Target occupancy by AMG 557 was dose dependent and reversible, and maximal occupancy was achieved in the setting of this trial. Anti-AMG 557 antibodies were observed, but none were neutralising and without impact on drug levels. A significant reduction in the anti-KLH IgG response was observed with AMG 557 administration without discernible changes in the anti-KLH IgM response or on the overall IgG levels. No discernible changes were seen in lymphocyte subsets or in SLE-related biomarkers and clinical measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The selective reduction in anti-KLH IgG demonstrates a PD effect of AMG 557 in subjects with SLE consistent with the biology of the ICOS pathway and supports further studies of AMG 557 as a potential therapeutic for autoimmune diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration numbers<\/jats:title><jats:p>NCT02391259 and<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00774943\">NCT00774943<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/lupus-2016-000146","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T22:15:52Z","timestamp":1465251352000},"page":"e000146","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":74,"title":["Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus"],"prefix":"10.1136","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct00774943","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"B A","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Boedigheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C L","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kaliyaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ferbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J B","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"2024051418220907000_3.1.e000146.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00769.x"},{"key":"2024051418220907000_3.1.e000146.2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2013.183","article-title":"Targeting co-stimulatory pathways: transplantation and autoimmunity","volume":"10","author":"Ford","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2024051418220907000_3.1.e000146.3","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21335"},{"key":"2024051418220907000_3.1.e000146.4","doi-asserted-by":"publisher","DOI":"10.1038\/nri3405"},{"key":"2024051418220907000_3.1.e000146.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.023"},{"key":"2024051418220907000_3.1.e000146.6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141432"},{"key":"2024051418220907000_3.1.e000146.7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101400"},{"key":"2024051418220907000_3.1.e000146.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.11.020"},{"key":"2024051418220907000_3.1.e000146.9","doi-asserted-by":"crossref","first-page":"e102791","DOI":"10.1371\/journal.pone.0102791","article-title":"Germinal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune mice","volume":"9","author":"Yusuf","year":"2014","journal-title":"PLoS ONE"},{"key":"2024051418220907000_3.1.e000146.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1257861"},{"key":"2024051418220907000_3.1.e000146.11","doi-asserted-by":"publisher","DOI":"10.1038\/ni902"},{"key":"2024051418220907000_3.1.e000146.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2955"},{"key":"2024051418220907000_3.1.e000146.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4927"},{"key":"2024051418220907000_3.1.e000146.14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803256"},{"key":"2024051418220907000_3.1.e000146.15","doi-asserted-by":"publisher","DOI":"10.1038\/35051100"},{"key":"2024051418220907000_3.1.e000146.16","doi-asserted-by":"publisher","DOI":"10.1038\/35051107"},{"key":"2024051418220907000_3.1.e000146.17","doi-asserted-by":"publisher","DOI":"10.1038\/35051113"},{"key":"2024051418220907000_3.1.e000146.18","doi-asserted-by":"publisher","DOI":"10.1385\/IR:28:1:39"},{"key":"2024051418220907000_3.1.e000146.19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000448"},{"key":"2024051418220907000_3.1.e000146.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00011-X"},{"key":"2024051418220907000_3.1.e000146.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-8411(03)00119-7"},{"key":"2024051418220907000_3.1.e000146.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016529"},{"key":"2024051418220907000_3.1.e000146.23","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1690"},{"key":"2024051418220907000_3.1.e000146.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature03555"},{"key":"2024051418220907000_3.1.e000146.25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081886"},{"key":"2024051418220907000_3.1.e000146.26","doi-asserted-by":"crossref","first-page":"e56436","DOI":"10.1371\/journal.pone.0056436","article-title":"Small intestine inflammation in Roquin-mutant and Roquin-deficient mice","volume":"8","author":"Schaefer","year":"2013","journal-title":"PLoS ONE"},{"key":"2024051418220907000_3.1.e000146.27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.8.4332"},{"key":"2024051418220907000_3.1.e000146.28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.2848"},{"key":"2024051418220907000_3.1.e000146.29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.3.1421"},{"key":"2024051418220907000_3.1.e000146.30","doi-asserted-by":"publisher","DOI":"10.1038\/89739"},{"key":"2024051418220907000_3.1.e000146.31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrrheum.2013.145","article-title":"Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys","volume":"10","author":"Thanou","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"2024051418220907000_3.1.e000146.32","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.136"},{"key":"2024051418220907000_3.1.e000146.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071297"},{"key":"2024051418220907000_3.1.e000146.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81108-3"},{"key":"2024051418220907000_3.1.e000146.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.20519"},{"key":"2024051418220907000_3.1.e000146.36","doi-asserted-by":"publisher","DOI":"10.1002\/art.25032"},{"key":"2024051418220907000_3.1.e000146.37","doi-asserted-by":"crossref","first-page":"827480","DOI":"10.1155\/2012\/827480","article-title":"Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis","volume":"2012","author":"Ma","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2024051418220907000_3.1.e000146.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.02.024"},{"key":"2024051418220907000_3.1.e000146.39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008146"},{"key":"2024051418220907000_3.1.e000146.40","doi-asserted-by":"crossref","first-page":"631787","DOI":"10.1155\/2014\/631787","article-title":"The Histopathology of labial salivary glands in primary Sjogren's syndrome: focusing on follicular helper T cells in the inflammatory infiltrates","volume":"2014","author":"Szabo","year":"2014","journal-title":"Mediators Inflamm"},{"key":"2024051418220907000_3.1.e000146.41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bcp.12172","article-title":"A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus","volume":"76","author":"Ferbas","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"2024051418220907000_3.1.e000146.42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2009.03.023","article-title":"Defining dose-response relationships in the therapeutic blockade of B7RP-1-dependent immune responses","volume":"610","author":"Metz","year":"2009","journal-title":"Eur.J.Pharmacol"},{"key":"2024051418220907000_3.1.e000146.43","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.170"},{"key":"2024051418220907000_3.1.e000146.44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106279"},{"key":"2024051418220907000_3.1.e000146.45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.165.3.865"},{"key":"2024051418220907000_3.1.e000146.46","doi-asserted-by":"publisher","DOI":"10.1038\/nature12058"},{"key":"2024051418220907000_3.1.e000146.47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.9.4689"},{"key":"2024051418220907000_3.1.e000146.48","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80117-X"},{"key":"2024051418220907000_3.1.e000146.49","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62990-2"},{"key":"2024051418220907000_3.1.e000146.50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaci.2014.12.1940","article-title":"A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens","volume":"136","author":"Chou","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2024051418220907000_3.1.e000146.51","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10875-015-0193-x","article-title":"Astute Clinician report: a novel 10 bp frameshift deletion in exon 2 of ICOS causes a combined immunodeficiency associated with an enteritis and hepatitis","volume":"35","author":"Robertson","year":"2015","journal-title":"J Clin Immunol"},{"key":"2024051418220907000_3.1.e000146.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61354-2"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2016-000146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T01:22:31Z","timestamp":1715736151000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2016-000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,8]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1136\/lupus-2016-000146"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2016-000146","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}